What does it take to run a truly patient-centric integrated health system? What does the Welsh journey with integration tell us about the future for England? Paul Mears (CEO, Cwm...
Read More
For our Global Whispers webinar in October, Clare Foy (Director – Global Market Access, Mtech Access) spoke to Italian market access expert Prof. Fabrizio Gianfrate (Professor of Health Economics and...
Read More
What does NHS primary care need from industry? In our October NHS Whispers webinar, Dr Farzana Hussain (GP Principal, The Project Surgery) and Prof. Phil Richardson (Chair and Chief Innovation...
Read More
How can our community support NHS leaders to deliver a data-led, people-centric health service? Dr Mark Davies (Global Chief Health Officer, IBM) joined Prof. Phil Richardson (Chair and Chief Innovation...
Read More
On Wednesday 16th August Calum Jones (Senior Consultant – Health Economics, Mtech Access) spoke to Dr George Magrath (CEO, Lexitas) about the use of AI in clinical trials, where and...
Read More
How is the UK political landscape evolving and what does this mean for Health Technology and Medical Device innovators? On Friday 28th July, Robert Hull (Senior Consultant – NHS Insight...
Read More
In this webinar, we explore market access challenges in Germany, Austria and Switzerland. Clare Foy (Global Market Access Director – Mtech Access) speaks to Dr Stefan Walzer (CEO, President &...
Read More
In the second episode of our Global Whispers webinar series, we explored market access for digital therapeutics. Clare Foy (Global Market Access Director – Mtech Access) spoke to Shefali Shah...
Read More
What does it take to bring a cannabinoid pharmaceutical to market? On Tuesday 23rd May Clare Foy (Global Market Access Director – Mtech Access) was joined by Michael Sassano (CEO...
Read More
What are surrogate endpoints and how can they support the accelerated approval of new medicines? Where and how are surrogate endpoints being used? In which disease areas and markets can...
Read More
